Latest Investments News

Acumentis Group Limited reported a robust FY25 with a 35% jump in operating profit, driven by strategic diversification and operational efficiency. The company is optimistic about FY26, anticipating economic improvements and new growth avenues.

Acumentis delivered a 3.4% revenue increase to $58.1 million at its 2025 AGM, highlighting diversification and a positive outlook for FY26 amid easing inflation and expected rate cuts.

King River Resources reports encouraging gold assay results from its Kurundi Project and promising soil geochemical anomalies at Kuiper IOCG targets, underpinning ongoing exploration momentum in the Tennant Creek region.

MAAS Group Holdings reported a 6% rise in FY25 underlying EBITDA to $219.4 million, driven by strong construction materials growth and strategic acquisitions. The company projects FY26 EBITDA between $240 million and $270 million, underpinned by renewable energy projects and a robust capital recycling program.

Aeris Resources reported solid Q1 FY26 results with steady copper and gold production, disciplined cost management, and advancing divestment plans for non-core assets.

Aeris Resources reported steady Q1 FY26 production with 10.3kt copper equivalent at AISC of A$4.64/lb, alongside significant growth capital investment and promising exploration results.

Dateline Resources’ Managing Director Stephen Baghdadi has increased his personal investment by exercising 13.86 million options, reinforcing confidence in the Colosseum Gold and Rare Earth Elements Project as feasibility studies progress.

Vitasora Health has received $2.43 million from a cornerstone investor, advancing its $11 million capital raise and reinforcing its path to profitability by Q4 FY2026. The company’s expanding US partnerships and technology investments signal growing market confidence.

Imricor Medical Systems made significant regulatory strides with FDA submissions for its MRI-guided cardiac ablation devices and launched NorthStar commercially in Europe, even as it reported increased cash outflows in Q3 CY25.

Apiam Animal Health Limited has entered a binding agreement with Adamantem Capital Fund II for a $228.4 million acquisition via a scheme of arrangement, offering shareholders a significant premium and flexible cash or scrip consideration options.

ACDC Metals reports compelling mineralogy results from its Goschen Central project, highlighting elevated rare earth element grades that reinforce its economic potential. The announcement coincides with strategic momentum from the Australia-US Critical Minerals Framework, positioning the project as a key player in global supply chains.

Eden Innovations reports a surge in US orders and quotations for its OptiBlend dual fuel kits, driven by growing demand from data centres. Recent sales exceed US$300k, with a robust pipeline of US$4.4 million signalling strong market momentum.